CAMKK1 and metabolic dysfunction-associated steatohepatitis: Some of the anti-steatotic or anti-inflammatory effects of MSC-EVs in MASH have been attributed to specific EV cargo molecules, such as miRs 24-3p, 96-5p, 223-3p, 627-5p and CAMKK1, raising the possibility that these components or their targets in the liver are new leads for therapeutic intervention, but future studies will likely identify a much broader slate of candidates.